Scalici named chief of gynecologic oncology at USA Health
Scalici will oversee the day-to-day operations of the division, which employs five gynecologic oncologists, two nurse practitioners and their support staff, and is the largest gynecologic oncology practice on the upper Gulf Coast.
By Carol McPhail
CMcPhail@health.southalabama.edu
Dr. Jennifer Scalici has been named chief of the gynecologic oncology service at USA Health Mitchell Cancer Institute.
Scalici will oversee the day-to-day operations of the division, which employs five gynecologic oncologists, two nurse practitioners and their support staff, and is the largest gynecologic oncology practice on the upper Gulf Coast.
“During her years at MCI, Dr. Scalici has excelled in all areas of academic medicine,” said Dr. Rodney P. Rocconi, interim director at the Mitchell Cancer Institute. “I look forward to her leadership and vision in moving the gynecologic oncology division forward as we continue to provide the highest level of patient care while searching for new and improved treatments for cancer.”
Since joining the Mitchell Cancer Institute in 2012, Scalici has built a clinical practice emphasizing minimally invasive and robotic surgery. She also conducts basic and translational research as director of the gynecologic oncology research team. Her current research, funded by a grant from the U.S. Department of Defense, examines the effectiveness of a novel compound in the prevention of ovarian cancer.
Scalici earned her medical degree from the University of Alabama at Birmingham before completing a residency at Northwestern University McGraw Medical Center in Chicago and a fellowship at the University of Virginia Health System in Charlottesville, Va.
